Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Pathol Clin Res ; 10(3): e12377, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38750616

RESUMO

Even after decades of research, pancreatic ductal adenocarcinoma (PDAC) remains a highly lethal disease and responses to conventional treatments remain mostly poor. Subclassification of PDAC into distinct biological subtypes has been proposed by various groups to further improve patient outcome and reduce unnecessary side effects. Recently, an immunohistochemistry (IHC)-based subtyping method using cytokeratin-81 (KRT81) and hepatocyte nuclear factor 1A (HNF1A) could recapitulate some of the previously established molecular subtyping methods, while providing significant prognostic and, to a limited degree, also predictive information. We refined the KRT81/HNF1A subtyping method to classify PDAC into three distinct biological subtypes. The prognostic value of the IHC-based method was investigated in two primary resected cohorts, which include 269 and 286 patients, respectively. In the second cohort, we also assessed the predictive effect for response to erlotinib + gemcitabine. In both PDAC cohorts, the new HNF1A-positive subtype was associated with the best survival, the KRT81-positive subtype with the worst, and the double-negative with an intermediate survival (p < 0.001 and p < 0.001, respectively) in univariate and multivariate analyses. In the second cohort (CONKO-005), the IHC-based subtype was additionally found to have a potential predictive value for the erlotinib-based treatment effect. The revised IHC-based subtyping using KRT81 and HNF1A has prognostic significance for PDAC patients and may be of value in predicting treatment response to specific therapeutic agents.


Assuntos
Biomarcadores Tumorais , Carcinoma Ductal Pancreático , Fator 1-alfa Nuclear de Hepatócito , Queratinas Tipo II , Neoplasias Pancreáticas , Valor Preditivo dos Testes , Feminino , Humanos , Masculino , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biomarcadores Tumorais/análise , Carcinoma Ductal Pancreático/patologia , Carcinoma Ductal Pancreático/mortalidade , Carcinoma Ductal Pancreático/metabolismo , Desoxicitidina/análogos & derivados , Desoxicitidina/uso terapêutico , Cloridrato de Erlotinib/uso terapêutico , Gencitabina , Fator 1-alfa Nuclear de Hepatócito/genética , Fator 1-alfa Nuclear de Hepatócito/metabolismo , Imuno-Histoquímica , Estimativa de Kaplan-Meier , Queratinas Específicas do Cabelo/metabolismo , Queratinas Específicas do Cabelo/análise , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/mortalidade , Neoplasias Pancreáticas/metabolismo , Prognóstico , Queratinas Tipo II/análise , Queratinas Tipo II/metabolismo
2.
Cells ; 12(23)2023 11 26.
Artigo em Inglês | MEDLINE | ID: mdl-38067138

RESUMO

The role of desmoglein-3 (DSG3) in oncogenesis is unclear. This study aimed to uncover molecular mechanisms through comparative transcriptome analysis in oral cancer cells, defining potential key genes and associated biological processes related to DSG3 expression. Four mRNA libraries of oral squamous carcinoma H413 cell lines were sequenced, and 599 candidate genes exhibited differential expression between DSG3-overexpressing and matched control lines, with 12 genes highly significantly differentially expressed, including 9 upregulated and 3 downregulated. Genes with known implications in cancer, such as MMP-13, KRT84, OLFM4, GJA1, AMOT and ADAMTS1, were strongly linked to DSG3 overexpression. Gene ontology analysis indicated that the DSG3-associated candidate gene products participate in crucial cellular processes such as junction assembly, focal adhesion, extracellular matrix formation, intermediate filament organisation and keratinocyte differentiation. Validation of RNA-Seq was performed through RT-qPCR, Western blotting and immunofluorescence analyses. Furthermore, using transmission electron microscopy, we meticulously examined desmosome morphology and revealed a slightly immature desmosome structure in DSG3-overexpressing cells compared to controls. No changes in desmosome frequency and diameter were observed between the two conditions. This study underscores intricate and multifaceted alterations associated with DSG3 in oral squamous carcinoma cells, implying a potential oncogenic role of this gene in biological processes that enable cell communication, motility and survival.


Assuntos
Carcinoma de Células Escamosas , Neoplasias Bucais , Humanos , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/metabolismo , Desmogleína 3/genética , Desmogleína 3/análise , Desmogleína 3/metabolismo , Desmossomos/metabolismo , Perfilação da Expressão Gênica , Queratinócitos/metabolismo , Queratinas Específicas do Cabelo/análise , Queratinas Específicas do Cabelo/genética , Queratinas Específicas do Cabelo/metabolismo , Queratinas Tipo II/análise , Queratinas Tipo II/genética , Queratinas Tipo II/metabolismo , Neoplasias Bucais/genética , Neoplasias Bucais/metabolismo , Oncogenes , Transcriptoma
3.
Biosci Rep ; 40(4)2020 04 30.
Artigo em Inglês | MEDLINE | ID: mdl-32181476

RESUMO

AIMS: Oral squamous cell carcinoma (OSCC) is a common oral cancer; however, current therapeutic approaches still show limited efficacy. Our research aims to explore effective biomarkers related to OSCC. MAIN METHODS: Gene expression profiles of paired OSCC tumor and paracancerous samples from The Cancer Genome Atlas (TCGA) were analyzed. mRNA and protein levels of KRT84 in OSCC cell line HSC-3 were measured by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot. KRT84 protein levels in OSCC tumor samples of different stages were determined by immunohistochemistry. Overall survival (OS) of OSCC samples was evaluated and association of multiple factors with OS was assessed. KEY FINDINGS: Compared with paracancerous samples, 4642 DEGs were identified in OSCC tumor samples. Among them, KRT84 expression level in OSCC tumor tissues was obviously decreased, which was validated in HSC-3 cells. KRT84 expression level showed decreasing tendency with the increase of tumor grade and stage. Patients with low KRT84 expression level had inferior OS independently of multiple factors. Besides, antigen processing and presentation pathway were significantly activated in OSCC samples with high KRT84 expression. Elevated KRT84 mRNA as well as protein levels were confirmed by RT-qPCR and Western blot in OSCC and normal cell lines, and immunohistochemistry in OSCC tumor and paracancerous tissues. SIGNIFICANCE: Our study suggests KRT84 as a tumor suppressor and good prognostic indicator for OSCC, which might be significant for OSCC diagnosis and treatment.


Assuntos
Biomarcadores Tumorais/metabolismo , Queratinas Específicas do Cabelo/metabolismo , Queratinas Tipo II/metabolismo , Neoplasias Bucais/patologia , Carcinoma de Células Escamosas de Cabeça e Pescoço/patologia , Proteínas Supressoras de Tumor/metabolismo , Biomarcadores Tumorais/análise , Linhagem Celular Tumoral , Conjuntos de Dados como Assunto , Feminino , Perfilação da Expressão Gênica , Humanos , Imuno-Histoquímica , Queratinas Específicas do Cabelo/análise , Queratinas Tipo II/análise , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/patologia , Neoplasias Bucais/diagnóstico , Neoplasias Bucais/mortalidade , Prognóstico , Carcinoma de Células Escamosas de Cabeça e Pescoço/diagnóstico , Carcinoma de Células Escamosas de Cabeça e Pescoço/mortalidade , Análise de Sobrevida , Proteínas Supressoras de Tumor/análise
4.
PLoS One ; 9(4): e93607, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24714551

RESUMO

Pure hair and nail ectodermal dysplasia (PHNED) comprises a heterogeneous group of rare heritable disorders characterized by brittle hair, hypotrichosis, onychodystrophy and micronychia. Autosomal recessive (AR) PHNED has previously been associated with mutations in either KRT85 or HOXC13 on chromosome 12p11.1-q14.3. We investigated a consanguineous Pakistani family with AR PHNED linked to the keratin gene cluster on 12p11.1 but without detectable mutations in KRT85 and HOXC13. Whole exome sequencing of affected individuals revealed homozygosity for a rare c.821T>C variant (p.Phe274Ser) in the KRT74 gene that segregates AR PHNED in the family. The transition alters the highly conserved Phe274 residue in the coil 1B domain required for long-range dimerization of keratins, suggesting that the mutation compromises the stability of intermediate filaments. Immunohistochemical (IHC) analyses confirmed a strong keratin-74 expression in the nail matrix, the nail bed and the hyponychium of mouse distal digits, as well as in normal human hair follicles. Furthermore, hair follicles and epidermis of an affected family member stained negative for Keratin-74 suggesting a loss of function mechanism mediated by the Phe274Ser substitution. Our observations show for the first time that homozygosity for a KRT74 missense variant may be associated with AR PHNED. Heterozygous KRT74 mutations have previously been associated with autosomal dominant woolly hair/hypotrichosis simplex (ADWH). Thus, our findings expand the phenotypic spectrum associated with KRT74 mutations and imply that a subtype of AR PHNED is allelic with ADWH.


Assuntos
Fissura Palatina/genética , Displasia Ectodérmica/genética , Cabelo/patologia , Hipotricose/genética , Deficiência Intelectual/genética , Queratinas Específicas do Cabelo/genética , Queratinas Tipo II/genética , Mutação de Sentido Incorreto , Unhas/patologia , Sindactilia/genética , Alelos , Sequência de Aminoácidos , Animais , Fissura Palatina/patologia , Consanguinidade , Displasia Ectodérmica/patologia , Cabelo/metabolismo , Homozigoto , Humanos , Hipotricose/patologia , Deficiência Intelectual/patologia , Queratinas Específicas do Cabelo/análise , Queratinas Tipo II/análise , Camundongos , Dados de Sequência Molecular , Unhas/metabolismo , Linhagem , Sindactilia/patologia
6.
In Vitro Cell Dev Biol Anim ; 46(8): 693-701, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20568020

RESUMO

Studies with hepatic progenitor cells from non-human primates would allow better understanding of their human counterparts. In this study, rhesus monkey liver epithelial progenitor cells (mLEPCs) were derived from a small piece of newborn livers in chemical defined serum-free medium. Digested hepatic cells were treated in Ca(2+)-containing medium to form cell aggregates. Two types of cell aggregates were generated: elongated spindle cells and polygonal epithelial cells. Elongated spindle cells were expressed as vimentin and brachyury, and they were disappeared within 5 d in our cultures. The remaining type consisted of small polygonal epithelial cells that expressed cytokeratin 7 (CK7), CK8, CK18, nestin, CD49f, and E-cad, the markers of hepatic stem cells, but were negative for alpha-fetoprotein, albumin, and CK19. They can proliferate and be passaged, if on laminin or rat tail collagen gel, to initiate colonies. When cultured with dexamethasone and oncostatin M, the expression of mature hepatocyte markers, such as alpha-1-antitrypsin, intracytoplasmic glycogen storage, indocyanine green uptake, and lipid droplet generation, were induced in differentiated cells. If transferred onto mouse embryonic fibroblasts feeders, they gave rise to CK19-positive cholangiocytes with formation of doughnut-like structure. Thus, mLEPCs with bipotency were derived from newborn monkey liver and may serve as a preclinical model for assessment of cell therapy in humans.


Assuntos
Técnicas de Cultura de Células , Células Epiteliais/citologia , Fígado/citologia , Células-Tronco/citologia , Animais , Animais Recém-Nascidos , Caderinas/análise , Agregação Celular , Diferenciação Celular , Meios de Cultura Livres de Soro , Dexametasona/farmacologia , Células Epiteliais/efeitos dos fármacos , Células Epiteliais/metabolismo , Integrina alfa6/análise , Proteínas de Filamentos Intermediários/análise , Queratinas Tipo II/análise , Fígado/efeitos dos fármacos , Fígado/metabolismo , Macaca mulatta , Camundongos , Proteínas do Tecido Nervoso/análise , Nestina , Oncostatina M/farmacologia , Ratos , Células-Tronco/efeitos dos fármacos , Células-Tronco/metabolismo , alfa 1-Antitripsina/análise
7.
Exp Cell Res ; 315(2): 226-39, 2009 Jan 15.
Artigo em Inglês | MEDLINE | ID: mdl-19000672

RESUMO

Tumor progression is characterized by definite changes in the protein composition of the nuclear matrix (NM). The interactions of chromatin with the NM occur via specific DNA sequences called MARs (matrix attachment regions). In the present study, we applied a proteomic approach along with a Southwestern assay to detect both differentially expressed and MAR-binding NM proteins, in persistent hepatocyte nodules (PHN) in respect with normal hepatocytes (NH). In PHN, the NM undergoes changes both in morphology and in protein composition. We detected over 500 protein spots in each two dimensional map and 44 spots were identified. Twenty-three proteins were differentially expressed; among these, 15 spots were under-expressed and 8 spots were over-expressed in PHN compared to NH. These changes were synchronous with several modifications in both NM morphology and the ability of NM proteins to bind nuclear RNA and/or DNA containing MARs sequences. In PHN, we observed a general decrease in the expression of the basic proteins that bound nuclear RNA and the over-expression of two species of Mw 135 kDa and 81 kDa and pI 6.7-7.0 and 6.2-7.4, respectively, which exclusively bind to MARs. These results suggest that the deregulated expression of these species might be related to large-scale chromatin reorganization observed in the process of carcinogenesis by modulating the interaction between MARs and the scaffold structure.


Assuntos
Neoplasias Hepáticas/metabolismo , Proteínas de Ligação à Região de Interação com a Matriz/metabolismo , Proteínas Associadas à Matriz Nuclear/metabolismo , Matriz Nuclear/metabolismo , Proteômica/métodos , Animais , Western Blotting , Proteínas de Ciclo Celular , Eletroforese em Gel Bidimensional , Proteínas de Choque Térmico/análise , Proteínas de Choque Térmico/metabolismo , Ribonucleoproteínas Nucleares Heterogêneas/análise , Ribonucleoproteínas Nucleares Heterogêneas/metabolismo , Queratinas Tipo II/análise , Queratinas Tipo II/metabolismo , Laminas/análise , Laminas/metabolismo , Neoplasias Hepáticas/patologia , Neoplasias Hepáticas/ultraestrutura , Masculino , Proteínas de Ligação à Região de Interação com a Matriz/análise , Microscopia Eletrônica , Matriz Nuclear/química , Matriz Nuclear/ultraestrutura , Proteínas Associadas à Matriz Nuclear/análise , Proteínas Nucleares/análise , Proteínas Nucleares/metabolismo , Ligação Proteica , RNA Nuclear/metabolismo , Proteínas de Ligação a RNA/análise , Proteínas de Ligação a RNA/metabolismo , Ratos , Ratos Endogâmicos F344 , Ribonucleosídeos/química , Ribonucleosídeos/metabolismo , Espectrometria de Massas em Tandem/métodos , Fatores de Tempo , Vanadatos/química , Vanadatos/metabolismo
8.
Ann Surg Oncol ; 14(6): 1896-903, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17356955

RESUMO

BACKGROUND: The sentinel lymph node (SLN) status has proven to accurately reflect the remaining axillary lymph nodes and represents the most important prognostic factor. It is unknown whether an association exists between the SLN status and the presence of bone marrow (BM) micrometastases. The objective of the present investigation was to evaluate whether or not such an association exists. METHODS: In the present investigation 410 patients with early stage breast cancer (pT1 and pT2

Assuntos
Neoplasias da Medula Óssea/secundário , Neoplasias da Mama/patologia , Biópsia de Linfonodo Sentinela , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais , Neoplasias da Medula Óssea/patologia , Corantes , Feminino , Humanos , Queratinas/análise , Queratinas Tipo I/análise , Queratinas Tipo II/análise , Metástase Linfática/patologia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Prognóstico , Estudos Prospectivos , Suíça
9.
Exp Eye Res ; 84(4): 680-6, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17289024

RESUMO

Posterior polymorphous corneal dystrophy (PPCD) is a hereditary bilateral disorder affecting Descemet's membrane and the endothelium. The aim of the present study was to determine the spectrum of cytokeratin (CK) expression in cells on the posterior surface of the cornea in PPCD patients. Ten corneal buttons and one specimen of the trabecular meshwork (TM) from PPCD patients who underwent graft or glaucoma surgery were used, as well as six corneal buttons and two TM specimens obtained from healthy donors as controls. Cryosections were fixed and indirect immunofluorescent staining was performed using antibodies directed against a wide spectrum of cytokeratins (CKs). The number of positive cells and the intensity of the staining were assessed using fluorescent microscopy. All 10 PPCD corneal specimens had areas of endothelium displaying typical endothelial morphology as well as areas consisting of layers two to six cells thick with both flat endothelial-like cells and polygonal cells with round nuclei and a large cytoplasm. Both of these morphologically distinct cell types showed strong immunostaining for CK7, CK19, CK8 and CK18, while weaker positive signals were observed for CK1, CK3/12, CK4, CK5/6, CK10, CK10/13, CK14, CK16 and CK17. PPCD endothelium was completely negative for CK2e, CK9, CK15, and CK20. Focal positivity was detected in PPCD TM for CK4, CK7 and CK19. CK8 and CK18 were the only CKs expressed in control endothelium. PPCD and control epithelium displayed similar staining patterns. The distinct positivity for CK3/12, CK4, CK5/6, CK10/13, CK14, CK16 and CK17 was observed in aberrant PPCD endothelium for the first time. We demonstrate that the abnormal endothelium of PPCD patients expresses a mixture of CKs, with CK7 and CK19 predominating. In terms of CK composition, the aberrant PPCD endothelium shares features of both simple and squamous stratified epithelium with a proliferative capacity. The wide spectrum of CK expression is most probably not indicative of the transformation of endothelial cells to a distinct epithelial phenotype, but more likely reflects the modified differentiation of metaplastic epithelium.


Assuntos
Distrofias Hereditárias da Córnea/metabolismo , Endotélio Corneano/metabolismo , Proteínas do Olho/análise , Queratinas/análise , Adolescente , Adulto , Idoso , Distrofias Hereditárias da Córnea/patologia , Endotélio Corneano/anormalidades , Endotélio Corneano/patologia , Feminino , Humanos , Imuno-Histoquímica/métodos , Queratinas Tipo I/análise , Queratinas Tipo II/análise , Masculino , Microscopia de Fluorescência/métodos , Pessoa de Meia-Idade , Malha Trabecular/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA